Hinge Health Financial Ratios
NYSE: HNGETechnologyEDP ServicesUSD
102.90+4.90 (+5.00%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Hinge Health ratio analysis
Hinge Health earned a net margin of -89.9% in FY 2025, down from -3.1% a year earlier. Gross margin was 79.6% compared with a median of 71.6% over the prior 2 years. Return on equity reached -295.7%, meaning Hinge Health generated -2.96 dollars of profit for every dollar of shareholders' equity.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Hinge Health financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Price / sales | 4.23 | — | — |
| Price / book | 13.92 | — | — |
| Gross margin | 79.6% | 76.8% | 66.3% |
| Operating margin | -92.9% | -8.2% | -44.6% |
| Net margin | -89.9% | -3.1% | -36.9% |
| Free cash flow margin | 29.0% | 12.3% | -22.5% |
| Return on equity (ROE) | -295.7% | — | — |
| Return on assets (ROA) | -70.9% | -1.8% | — |
| Current ratio | 1.47 | 2.34 | — |
| Revenue growth | 50.6% | 33.4% | — |